Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruiqing Sun

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cancer Letters|November 18, 2025
Corrigendum to "Gobal crotonylome reveals that HNRNPC and its crotonylation promote p53-deficient tumor growth by stabilizing CCND1 and MCM3 mRNAs" [Cancer Lett. 628 (2025) 217854]Liangjie Sun, Xiaolei Gao, Meng Wang, et al.
Hepatology Communications|October 10, 2022
Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acidDawei Ding, Guanya Guo, Yansheng Liu, et al.
Cureus|November 18, 2021
Neuromodulation in Intractable Epilepsy Through Responsive Vagal Nerve Stimulation: A Three-Year Retrospective Study at the University of Texas Medical Branch, GalvestonJoseph Villarreal, Vijaya Lakshmi Valaparla, Kyra Curtis, et al.
Cancer Letters|June 7, 2025
Gobal crotonylome reveals that HNRNPC and its crotonylation promote p53-deficient tumor growth by stabilizing CCND1 and MCM3 mRNAsLiangjie Sun, Xiaolei Gao, Meng Wang, et al.
Journal of Translational Internal Medicine|August 27, 2025
Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteriaDawei Ding, Lina Cui, Gui Jia, et al.
ACS Applied Materials & Interfaces|December 2, 2025
Machine Learning-Assisted Ratiometric Fluorescence Electrospun Nanofiber Films for Portable and Intelligent Monitoring of Multiple Alkylresorcinol Homologues in Whole Wheat FoodsRuiqing Sun, Yujuan Xie, Xinpeng Zhou, et al.
Hepatology International|December 11, 2024
Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatmentDawei Ding, Yinan Hu, Gui Jia, et al.
The American Journal of Gastroenterology|March 9, 2023
Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A Randomized Clinical TrialYansheng Liu, Guanya Guo, Linhua Zheng, et al.
Gastroenterologia Y Hepatologia|January 12, 2023
Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acidDawei Ding, Pengwei Ren, Guanya Guo, et al.
International Journal of Molecular Medicine|January 22, 2015
Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κBLei Qiu, Guojian Yin, Li Cheng, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancer Letters|November 18, 2025
Corrigendum to "Gobal crotonylome reveals that HNRNPC and its crotonylation promote p53-deficient tumor growth by stabilizing CCND1 and MCM3 mRNAs" [Cancer Lett. 628 (2025) 217854]Liangjie Sun, Xiaolei Gao, Meng Wang, et al.
Hepatology Communications|October 10, 2022
Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acidDawei Ding, Guanya Guo, Yansheng Liu, et al.
Cureus|November 18, 2021
Neuromodulation in Intractable Epilepsy Through Responsive Vagal Nerve Stimulation: A Three-Year Retrospective Study at the University of Texas Medical Branch, GalvestonJoseph Villarreal, Vijaya Lakshmi Valaparla, Kyra Curtis, et al.
Cancer Letters|June 7, 2025
Gobal crotonylome reveals that HNRNPC and its crotonylation promote p53-deficient tumor growth by stabilizing CCND1 and MCM3 mRNAsLiangjie Sun, Xiaolei Gao, Meng Wang, et al.
Journal of Translational Internal Medicine|August 27, 2025
Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteriaDawei Ding, Lina Cui, Gui Jia, et al.
ACS Applied Materials & Interfaces|December 2, 2025
Machine Learning-Assisted Ratiometric Fluorescence Electrospun Nanofiber Films for Portable and Intelligent Monitoring of Multiple Alkylresorcinol Homologues in Whole Wheat FoodsRuiqing Sun, Yujuan Xie, Xinpeng Zhou, et al.
Hepatology International|December 11, 2024
Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatmentDawei Ding, Yinan Hu, Gui Jia, et al.
The American Journal of Gastroenterology|March 9, 2023
Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A Randomized Clinical TrialYansheng Liu, Guanya Guo, Linhua Zheng, et al.
Gastroenterologia Y Hepatologia|January 12, 2023
Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acidDawei Ding, Pengwei Ren, Guanya Guo, et al.
International Journal of Molecular Medicine|January 22, 2015
Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κBLei Qiu, Guojian Yin, Li Cheng, et al.
Pageof 5